BZYR
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Feb 26 closing price
Capitalization
7.61M
PYPD
Price
$2.74
Change
-$0.13 (-4.53%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
27.92M
57 days until earnings call
Ad is loading...

BZYR vs PYPD

Header iconBZYR vs PYPD Comparison
Open Charts BZYR vs PYPDBanner chart's image
Burzynski Research Institute
Price$0.06
Change+$0.01 (+20.00%)
Volume$7.42K
Capitalization7.61M
PolyPid
Price$2.74
Change-$0.13 (-4.53%)
Volume$181
Capitalization27.92M
BZYR vs PYPD Comparison Chart
Loading...
View a ticker or compare two or three
VS
BZYR vs. PYPD commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BZYR is a Hold and PYPD is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (BZYR: $0.06 vs. PYPD: $2.91)
Brand notoriety: BZYR and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BZYR: 120% vs. PYPD: 90%
Market capitalization -- BZYR: $7.61M vs. PYPD: $27.92M
BZYR [@Biotechnology] is valued at $7.61M. PYPD’s [@Biotechnology] market capitalization is $27.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BZYR’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • BZYR’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than BZYR.

Price Growth

BZYR (@Biotechnology) experienced а +21.89% price change this week, while PYPD (@Biotechnology) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

BZYR is expected to report earnings on Jan 13, 2023.

PYPD is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
PYPD($27.9M) has a higher market cap than BZYR($7.61M). BZYR YTD gains are higher at: 86.774 vs. PYPD (-4.115). BZYR has higher annual earnings (EBITDA): -1.46M vs. PYPD (-25.12M). PYPD has more cash in the bank: 9.53M vs. BZYR (613). BZYR (0) and PYPD (0) have equivalent revenues.
BZYRPYPDBZYR / PYPD
Capitalization7.61M27.9M27%
EBITDA-1.46M-25.12M6%
Gain YTD86.774-4.115-2,109%
P/E RatioN/AN/A-
Revenue00-
Total Cash6139.53M0%
Total DebtN/A10M-
FUNDAMENTALS RATINGS
BZYR: Fundamental Ratings
BZYR
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

BZYR and

Correlation & Price change

A.I.dvisor tells us that BZYR and FGHQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BZYR and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BZYR
1D Price
Change %
BZYR100%
N/A
FGHQF - BZYR
24%
Poorly correlated
N/A
NERV - BZYR
22%
Poorly correlated
+3.27%
ENVB - BZYR
22%
Poorly correlated
-18.46%
PYPD - BZYR
21%
Poorly correlated
-1.60%
CSLLY - BZYR
9%
Poorly correlated
+1.36%
More

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
-1.60%
ELEV - PYPD
30%
Poorly correlated
+1.52%
RAPT - PYPD
26%
Poorly correlated
+4.76%
SLGL - PYPD
25%
Poorly correlated
-2.83%
MESO - PYPD
25%
Poorly correlated
-4.54%
ASPHF - PYPD
24%
Poorly correlated
N/A
More